• Chinese FDA clearance for the IDS-iSYS instrument

News & Views

Chinese FDA clearance for the IDS-iSYS instrument

Oct 25 2014

Immunodiagnostic Systems Holdings PLC (IDS) has received notice that the China Food and Drug Administration (“CFDA”) has approved the company's IDS-iSYS automated immunoassay instrument for sale in the Chinese market.

In May 2013 IDS appointed Beijing Leadman Biochemistry Technology Co Ltd as its exclusive distributor for the IDS-iSYS instrument and assays in the People's Republic of China. Since May 2013 IDS have been working closely with Leadman on CFDA clearance for the IDS-iSYS instrument as well as a number of Leadman and IDS automated immunoassays for use on the IDS-iSYS.

Patrik Dahlen CEO of IDS commented, "We are delighted to receive the CFDA clearance of the IDS-iSYS instrument within our projected timeframe. This approval is a key milestone in allowing us to access the large and fast growing Chinese diagnostic market. The next step is to gain CFDA approval for the automated assays for use on the IDS-iSYS and we continue to work closely with our Chinese partner, Leadman, in order to achieve this.”


Digital Edition

LMUK 49.7 Nov 2024

November 2024

News - Research & Events News   - News & Views Articles - They’re burning the labs... Spotlight Features - Incubators, Freezers & Cooling Equipment - Pumps, Valves & Liquid Hand...

View all digital editions

Events

MEDICA 2024

Nov 11 2024 Dusseldorf, Germany

FILTECH

Nov 12 2024 Cologne, Germany

Intech

Nov 12 2024 Tel Aviv, Israel

analytica China

Nov 18 2024 Shanghai, China

Pharma Asia

Nov 20 2024 Karachi, Pakistan

View all events